Illumina ILMN today announced that a federal jury in
Tacoma, Washington found that Illumina's BeadChip array product
infringed U.S. Patent No. 6,951, 682, asserted by Syntrix Biosystems,
Inc. The federal jury ordered Illumina to pay approximately $96 million
in damages to Syntrix based on a royalty rate of six percent for
BeadChip products sold by Illumina from 2005 through May 2012. United
States District Court Judge Benjamin H. Settle, however, dismissed from
the case claims that Illumina's alleged infringement was willful and
that Illumina misappropriated Syntrix's trade secrets. The Syntrix
patent expires on September 17, 2019.
Illumina continues to believe that Syntrix's claims are without merit.
Illumina intends to file post-trial motions asking
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in